203 related articles for article (PubMed ID: 38165538)
1. Preclinical evaluation of an
Wodtke R; Laube M; Hauser S; Meister S; Ludwig FA; Fischer S; Kopka K; Pietzsch J; Löser R
EJNMMI Radiopharm Chem; 2024 Jan; 9(1):1. PubMed ID: 38165538
[TBL] [Abstract][Full Text] [Related]
2. Development of an
Wodtke R; Wodtke J; Hauser S; Laube M; Bauer D; Rothe R; Neuber C; Pietsch M; Kopka K; Pietzsch J; Löser R
J Med Chem; 2021 Mar; 64(6):3462-3478. PubMed ID: 33705656
[TBL] [Abstract][Full Text] [Related]
3. The Impact of
Heerwig A; Kick A; Sommerfeld P; Eimermacher S; Hartung F; Laube M; Fischer D; Pietzsch HJ; Pietzsch J; Löser R; Mertig M; Pietsch M; Wodtke R
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675164
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Impact of structural alterations on the radiopharmacological profile of
Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
[TBL] [Abstract][Full Text] [Related]
6. Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates.
Hauser S; Sommerfeld P; Wodtke J; Hauser C; Schlitterlau P; Pietzsch J; Löser R; Pietsch M; Wodtke R
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562866
[TBL] [Abstract][Full Text] [Related]
7. N
Wodtke R; Hauser C; Ruiz-Gómez G; Jäckel E; Bauer D; Lohse M; Wong A; Pufe J; Ludwig FA; Fischer S; Hauser S; Greif D; Pisabarro MT; Pietzsch J; Pietsch M; Löser R
J Med Chem; 2018 May; 61(10):4528-4560. PubMed ID: 29664627
[TBL] [Abstract][Full Text] [Related]
8. Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile.
Bouvet V; Wuest M; Bailey JJ; Bergman C; Janzen N; Valliant JF; Wuest F
Mol Imaging Biol; 2017 Dec; 19(6):923-932. PubMed ID: 28639122
[TBL] [Abstract][Full Text] [Related]
9. Radiopharmacological evaluation of (18)F-labeled phosphatidylserine-binding peptides for molecular imaging of apoptosis.
Wuest M; Perreault A; Kapty J; Richter S; Foerster C; Bergman C; Way J; Mercer J; Wuest F
Nucl Med Biol; 2015 Nov; 42(11):864-74. PubMed ID: 26205076
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
11. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
[TBL] [Abstract][Full Text] [Related]
14. (18)F-glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation.
Maschauer S; Haubner R; Kuwert T; Prante O
Mol Pharm; 2014 Feb; 11(2):505-15. PubMed ID: 24325589
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4.
Mamat C; Mosch B; Neuber C; Köckerling M; Bergmann R; Pietzsch J
ChemMedChem; 2012 Nov; 7(11):1991-2003. PubMed ID: 23042640
[TBL] [Abstract][Full Text] [Related]
16. Radiosynthesis and Biological Evaluation of [
Litchfield M; Wuest M; Glubrecht D; Wuest F
Mol Pharm; 2020 Jan; 17(1):251-261. PubMed ID: 31816246
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer's disease.
Sundaram GS; Dhavale D; Prior JL; Sivapackiam J; Laforest R; Kotzbauer P; Sharma V
EJNMMI Res; 2015 Dec; 5(1):112. PubMed ID: 26061601
[TBL] [Abstract][Full Text] [Related]
18. Automated synthesis of [(18)F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models.
Bouvet V; Wuest M; Jans HS; Janzen N; Genady AR; Valliant JF; Benard F; Wuest F
EJNMMI Res; 2016 Dec; 6(1):40. PubMed ID: 27142881
[TBL] [Abstract][Full Text] [Related]
19. Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice.
Li Y; Liu Z; Lozada J; Wong MQ; Lin KS; Yapp D; Perrin DM
Nucl Med Biol; 2013 Nov; 40(8):959-66. PubMed ID: 24090672
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [
Sun P; Han Y; Zhu Y; Hu K; Huang S; Tan J; Wang M; Wu H; Tang G
Nucl Med Biol; 2020; 88-89():1-9. PubMed ID: 32580089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
